{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "PLX",
      "openfda": {
        "k_number": [
          "DEN140022"
        ],
        "registration_number": [
          "3016458380",
          "3042228518"
        ],
        "fei_number": [
          "3016458380",
          "3042228518"
        ]
      },
      "review_panel": "OP",
      "medical_specialty": "OP",
      "device_name": "Tear Duct Occluder",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Ophthalmic",
      "device_class": "1",
      "definition": "A nasolacrimal compression device is a device used to compress the nasolacrimal ducts to reduce drainage by means of temporary occlusion of the nasolacrimal system.  The device may include a nose piece attached to a frame to apply pressure to the duct.",
      "regulation_number": "886.5838",
      "implant_flag": "N",
      "submission_type_id": "4"
    }
  ]
}